Immune Suppression in Head and Neck Cancers: A Review

Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancer in the world. Despite significant advances in the treatment modalities involving surgery, radiotherapy, and concomitant chemoradiotherapy, the 5-year survival rate remained below 50% for the past 30 years. The worse pro...

Full description

Saved in:
Bibliographic Details
Main Authors: Anaëlle Duray, Stéphanie Demoulin, Pascale Hubert, Philippe Delvenne, Sven Saussez
Format: Article
Language:English
Published: Wiley 2010-01-01
Series:Clinical and Developmental Immunology
Online Access:http://dx.doi.org/10.1155/2010/701657
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849399300744806400
author Anaëlle Duray
Stéphanie Demoulin
Pascale Hubert
Philippe Delvenne
Sven Saussez
author_facet Anaëlle Duray
Stéphanie Demoulin
Pascale Hubert
Philippe Delvenne
Sven Saussez
author_sort Anaëlle Duray
collection DOAJ
description Head and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancer in the world. Despite significant advances in the treatment modalities involving surgery, radiotherapy, and concomitant chemoradiotherapy, the 5-year survival rate remained below 50% for the past 30 years. The worse prognosis of these cancers must certainly be link to the fact that HNSCCs strongly influence the host immune system. We present a critical review of our understanding of the HNSCC escape to the antitumor immune response such as a downregulation of HLA class I and/or components of APM. Antitumor responses of HNSCC patients are compromised in the presence of functional defects or apoptosis of T-cells, both circulating and tumor-infiltrating. Langerhans cells are increased in the first steps of the carcinogenesis but decreased in invasive carcinomas. The accumulation of macrophages in the peritumoral areas seems to play a protumoral role by secreting VEGF and stimulating the neoangiogenesis.
format Article
id doaj-art-9c84e36263544d2ea6e8cc991f95f092
institution Kabale University
issn 1740-2522
1740-2530
language English
publishDate 2010-01-01
publisher Wiley
record_format Article
series Clinical and Developmental Immunology
spelling doaj-art-9c84e36263544d2ea6e8cc991f95f0922025-08-20T03:38:22ZengWileyClinical and Developmental Immunology1740-25221740-25302010-01-01201010.1155/2010/701657701657Immune Suppression in Head and Neck Cancers: A ReviewAnaëlle Duray0Stéphanie Demoulin1Pascale Hubert2Philippe Delvenne3Sven Saussez4Laboratory of Anatomy, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, BelgiumDepartment of Pathology, CHU Sart-Tilman, University of Liège, 4000 Liège, BelgiumDepartment of Pathology, CHU Sart-Tilman, University of Liège, 4000 Liège, BelgiumDepartment of Pathology, CHU Sart-Tilman, University of Liège, 4000 Liège, BelgiumLaboratory of Anatomy, Faculty of Medicine and Pharmacy, University of Mons, 7000 Mons, BelgiumHead and neck squamous cell carcinomas (HNSCCs) are the sixth most common cancer in the world. Despite significant advances in the treatment modalities involving surgery, radiotherapy, and concomitant chemoradiotherapy, the 5-year survival rate remained below 50% for the past 30 years. The worse prognosis of these cancers must certainly be link to the fact that HNSCCs strongly influence the host immune system. We present a critical review of our understanding of the HNSCC escape to the antitumor immune response such as a downregulation of HLA class I and/or components of APM. Antitumor responses of HNSCC patients are compromised in the presence of functional defects or apoptosis of T-cells, both circulating and tumor-infiltrating. Langerhans cells are increased in the first steps of the carcinogenesis but decreased in invasive carcinomas. The accumulation of macrophages in the peritumoral areas seems to play a protumoral role by secreting VEGF and stimulating the neoangiogenesis.http://dx.doi.org/10.1155/2010/701657
spellingShingle Anaëlle Duray
Stéphanie Demoulin
Pascale Hubert
Philippe Delvenne
Sven Saussez
Immune Suppression in Head and Neck Cancers: A Review
Clinical and Developmental Immunology
title Immune Suppression in Head and Neck Cancers: A Review
title_full Immune Suppression in Head and Neck Cancers: A Review
title_fullStr Immune Suppression in Head and Neck Cancers: A Review
title_full_unstemmed Immune Suppression in Head and Neck Cancers: A Review
title_short Immune Suppression in Head and Neck Cancers: A Review
title_sort immune suppression in head and neck cancers a review
url http://dx.doi.org/10.1155/2010/701657
work_keys_str_mv AT anaelleduray immunesuppressioninheadandneckcancersareview
AT stephaniedemoulin immunesuppressioninheadandneckcancersareview
AT pascalehubert immunesuppressioninheadandneckcancersareview
AT philippedelvenne immunesuppressioninheadandneckcancersareview
AT svensaussez immunesuppressioninheadandneckcancersareview